Stifel Keeps Buy Rating on Scotts Miracle-Gro (SMG) Despite Slower May Sales
Stifel reiterated a Buy rating on Scotts Miracle-Gro (SMG) but cut its price target to $75 from $76 on June 8, citing updated FY2026–FY2028 estimates after the company’s update. Scotts reaffirmed FY2026 guidance, though branded point-of-sale data showed slower May sales. UBS lowered its objective to $63 from $70 and kept Neutral, citing softer demand, weather, weaker spending, and higher input costs.
How this was made
The 30-second read
Why it matters
The newest concrete detail is that updated branded point-of-sale data indicated sales trends slowed in May, prompting estimate revisions while guidance was reaffirmed.
Market read
For SMG, the trading takeaway is a cautious read-through from slower May branded POS that is reflected in lowered targets, even as ratings remain supportive.
What to watch
The article doesn’t quantify the magnitude of the May slowdown or margin impact; traders may need the underlying branded POS dataset and any subsequent management commentary to gauge whether this is a trend break or noise.
Background
The piece summarizes analyst actions (Stifel and UBS) around Scotts Miracle-Gro’s recent update and branded point-of-sale data.
Ticker impact
Stifel reiterated a Buy on Scotts Miracle-Gro while lowering its price recommendation to $75 and citing slower May branded POS trends.
Likely modest downside/limited upside bias versus prior target as slower May trends reinforce caution, despite Buy ratings.
The article’s actionable change is analyst target/estimate revisions tied to slower May sales trends; it is not a new earnings/guidance print, so magnitude should be moderate.
Market effects
Signals continued pressure on lawn/garden demand and consumer spending, which can affect sentiment across discretionary consumer/seasonal retailers.
No specific regional impact described.
No explicit global macro linkage beyond general demand/input-cost commentary.
Counterpoint
Despite slower May POS, management guidance is reaffirmed and UBS still views FY2026 targets as achievable, suggesting the slowdown may be temporary or offset by pricing/mix.
Key entities
- companyScotts Miracle-Gro Company
Subject of the article; analyst actions and May branded POS slowdown are discussed.
- analyst_firmStifel
Lowered its price recommendation to $75 from $76 and reiterated Buy, revising FY2026-FY2028 estimates.
- analyst_firmUBS
Reduced its price objective to $63 from $70 and kept Neutral ahead of a conference presentation.
